Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Gibco™ CTS™ DynaXS™ Single Use Bioreactor, a purpose-built expansion platform designed to help cell therapy ...

Laboratory experiments exposed E. coli and MRSA to Nu-3 for 21 days. The minimum inhibitory concentration (MIC) changed in E. coli, while MRSA showed no change.

Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward” or the "Company”), a global leader in innovative medical technology to transform the ...

ABUJA/JOS--The meeting between the Federal Government and the non-academic staff in the nation's public universities yesterday ended in a deadlock as the nationwide strike by members Senior Staff ...

Total test volumes grew 29% year over year due to increased adoption from both pulmonology and primary care, with test ...

The psychedelic industry is ballooning as new clinical trials spark increased drug development in a race to bring drugs to ...

Leading experts across cell therapy, oncology, and immunology will provide strategic input as Legend advances and expands ...

The 5th Circuit’s ruling on mifepristone “is bad for health care access, and it’s also bad for innovation,” writes Grace E.

U.S. District Court Judge Mustafa Kasubhai said the CEO of ApolloMD and the owner of Lane Emergency Physicians were dishonest ...

The rising prevalence of diseases in both developed and developing nations highlights the need to explore new pharmaceutical ...